Stockreport

Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer's Disease Patients [Yahoo! Finance]

Athira Pharma, Inc.  (ATHA) 
PDF Two key opinion leaders will discuss ongoing unmet medical need and LIFT-AD's primary endpoint, the Global Statistical Test, designed to measure overall impact on disea [Read more]